Please use a PC Browser to access Register-Tadawul
This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
First Look Media, Inc. FRST | 9.89 | +0.61% |
Neurosense Therapeutics Ltd. NRSN | 2.38 | -4.42% |
Putnam New York Investment Grade Municipal Trust PMN | 0.52 | -2.80% |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- D. Boral Capital analyst Jason Kolbert initiated coverage on NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) with a Buy rating and announced a price target of $14. NeuroSense Therapeutics shares closed at $1.0438 on Friday. See how other analysts view this stock.
- Maxim Group analyst Jason McCarthy initiated coverage on ProMIS Neurosciences, Inc. (NASDAQ:PMN) with a Buy rating and announced a price target of $3. ProMIS Neurosciences shares closed at $0.5020 on Friday. See how other analysts view this stock.
- Maxim Group initiated coverage on Primis Financial Corp. (NASDAQ:FRST) with a Buy rating and announced a price target of $1. Primis Finl shares closed at $8.96 on Friday. See how other analysts view this stock.
Considering buying NRSN stock? Here’s what analysts think:

Read This Next:
- 5 Stock Picks Last Week From Wall Street’s Most Accurate Analysts
Photo via Shutterstock